Paychex (PAYX) Form 4: 855 RSUs granted; options at $127.52

Paychex (PAYX) reported insider activity.

Rhea-AI Filing Summary

Paychex (PAYX) reported insider activity. A reporting person who is a Director and Chairman received 855 restricted stock units on 10/15/2025 at a price of $0 under the Amended and Restated 2002 Stock Incentive Plan. The person also received a stock option for 3,607 shares with an exercise price of $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.

Following these transactions, the filer reported 426,324.3318 shares beneficially owned, held directly. The filing also lists previously granted option awards with various exercise prices and expiration dates.

Insider Trade Summary

Grant/Award: 4,462 shares

Grant/Award 11 txns

Insider MUCCI MARTIN

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	3,607	$127.52	$460K
Grant/Award	Common Stock	855	$0.00	$0.00
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--
holding	Stock Option	--	--	--

Holdings After Transaction: Stock Option — 908,045 contracts for 904,438 underlying shares (Direct); Common Stock — 426,324.3318 shares (Direct)

Footnotes (1)

1. F1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Paychex (PAYX) disclose in this Form 4?

A reporting person received 855 RSUs at $0 and a stock option for 3,607 shares at an exercise price of $127.52 on 10/15/2025.

What is the exercise price and term of the new Paychex option grant?

The option covers 3,607 shares at $127.52, first exercisable on 10/15/2026 and expiring on 10/14/2035.

How many Paychex shares are beneficially owned after the transactions?

The reporting person disclosed 426,324.3318 shares beneficially owned, held directly.

What roles does the reporting person hold at Paychex (PAYX)?

The individual is disclosed as a Director and Chairman.

Under what plan were the RSUs awarded?

The 855 RSUs were awarded under the Amended and Restated 2002 Stock Incentive Plan and are subject to vesting.

Does the filing list other outstanding options?

Yes. It lists multiple prior option awards with various exercise prices and expiration dates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/17/2025 - 04:00 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MUCCI MARTIN

(Last) (First) (Middle)

911 PANORAMA TRAIL S.

(Street)

ROCHESTER NY 14625

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PAYCHEX INC [ PAYX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)	X	Other (specify below)
			Chairman

3. Date of Earliest Transaction (Month/Day/Year)
10/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/15/2025		A		855(1)	A	$0	426,324.3318	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option	$127.52	10/15/2025		A		3,607		10/15/2026	10/14/2035	Common Stock	3,607	$127.52	3,607	D
Stock Option	$57.24							07/12/2018	07/11/2027	Common Stock	214,482		214,482	D
Stock Option	$69.54							07/11/2019	07/10/2028	Common Stock	179,191		179,191	D
Stock Option	$85.46							07/10/2020	07/09/2029	Common Stock	195,228		195,228	D
Stock Option	$73.53							07/15/2021	07/14/2030	Common Stock	195,428		195,428	D
Stock Option	$112.67							07/15/2022	07/14/2031	Common Stock	108,086		108,086	D
Stock Option	$109.19							10/15/2023	10/14/2032	Common Stock	3,299		3,299	D
Stock Option	$120.86							07/15/2024	07/14/2033	Common Stock	3,985		3,985	D
Stock Option	$121.63							07/15/2025	07/14/2034	Common Stock	3,949		3,949	D
Stock Option	$140.68							07/15/2026	07/14/2035	Common Stock	790		790	D

Explanation of Responses:

1. Award of restricted stock units, subject to vesting, pursuant to the Amended and Restated 2002 Stock Incentive Plan.

	Prabha S. Bhandari, Attorney-in-fact	10/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.